Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safety.

Forier BartSchaevers VeroniqueIsabel Spriet Charlotte Quintens Stefanie Desmet Saskia BosVan Bleyenbergh PascalNatalie Lorent De Sadeleer Laurens Laurent Godinas J Dupont Lieven Robin Vos

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)

OPAT is an effective and safe therapeutic modality for bacterial eradication post-LTx, associated with a significant reduction in hospitalization days and treatment costs.

Keyphrases

cystic fibrosis
pseudomonas aeruginosa
helicobacter pylori infection
lung function
stem cells
mesenchymal stem cells
smoking cessation